The plan-act-study-do QI methodology was used to identify potential hazardous drug exposures and implement procedures to minimize those risks.

Parabilis Medicines, a clinical-stage biopharmaceutical company committed to creating extraordinary medicines for people living with cancer, today announced preliminary clinical and preclinical ...

REGIONS NEWS NuCana Presents Encouraging Data on NUC-7738 in Combination with PD-1 Inhibitors using Primary Patient-Derived Organoids and Autologous Tumor-Infiltrating Lymphocytes at the ESMO Congress ...

Responses were rapid and durable, and tumor shrinkage was observed in 82 percent of patients New findings from this investigational study build on the strength ...

Subcutaneous RYBREVANT®▼ (amivantamab) delivers promising 45 percent overall response rate with median duration of response of 7.2 months in recurrent or metastatic head and neck cancer ...

Dermatologists Say This Affordable Tool Can Smooth And Sculpt Your Face. Here's Exactly How To Use It.

The skin on different areas of the body requires different regimens. Here’s how dermatologists recommend treating it on your ...

The federal Food and Drug Administration today approved a new menopause drug that reduces hot flashes and night sweats after ...

The US Food and Drug Administration has approved another once-a-day pill that works without hormones to treat moderate to severe hot flashes in menopausal women, drugmaker Bayer said ...

For optimal white mold control, Brown says to apply Zorina fungicide preventively at full bloom when soybean, dry bean and ...

Alphamab Oncology (stock code: 9966.HK) announced that two latest clinical data on biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003 for the treatment of primary platinum-refractory ...